Genia Turanova, Chief Investment Strategist for Game-Changing Stocks and Fast-Track Millionaire, is a financial writer and money manager whose experience includes serving for more than a decade as a portfolio manager and Investment Committee member for a New York-based money management firm. Genia also researched, wrote and managed recommendations for several investment advisories. From 2011 to 2016, she served as Editor of the award-winning Leeb Income Performance newsletter. Genia also wrote for The Complete Investor, another award winner, from 2003 to 2016. During that time, Genia was responsible for several portfolios, including the "Income/Value" portfolio and the "FastTrack" portfolio. Genia's academic credentials include an MBA in Finance and Investments from the Zicklin School of Business, Baruch College in New York City. Genia is a CFA Charterholder.
Analyst Articles
It was only a matter of time before cash-rich Gilead Sciences (Nasdaq: GILD) moved to make a significant acquisition. The biotech company’s core business in hepatitis C was slowing, and investors no longer were willing to pay any kind of premium for shares. In fact, even today, GILD… Read More
We’re Down to Our Last Nine Passes Today is your absolute last chance to get all the research we publish at a $1,500 discount. Don’t let this chance slip away, sign up now. Innovation comes in different forms and… Read More
Never Pay for Your Subscription Again You need to check this out. This new program lets you waive your subscription costs forever! But that’s just the start… Go here to see all your other benefits. You won’t believe what this can do for your children. Read More
Get your share of the $75,000 FREE Giveaway Until September 1st, we’re celebrating our anniversary with FREE subscriptions… FREE reports… and we’re even giving out $1,500 refund checks to 50 people. Click here to see if you’re one. Read More
Shares of Paratek Pharmaceuticals (Nasdaq: PRTK) are more than 30% higher this morning on a report from Bloomberg that the antibiotics maker is exploring “strategic options,” including “a sale amid takeover interest from larger drugmakers.” Bloomberg, citing “people familiar… Read More
This Company Leads the Modern Marketing Migration Read More
Honestly, even one would have been big news. But just a couple of weeks ago, in a single day,...
Read More
Honestly, even one would have been big news. But just a couple of weeks ago, in a single day, two U.S.-listed high-yielding companies moved to either significantly reduce or eliminate their...
Read More
When we think of advertising and marketing, most of us still think of Madison Avenue, 30-second TV ads and annoying jingles. But the game is changing. In fact, the internet, social media, big data and other technology have transformed… Read More
Recently my team and I have been telling my readers about a quiet revolution that’s taking...
Read More
Recently my team and I have been telling my readers about a quiet revolution that’s taking place thanks to eccentric billionaire Elon Musk and his band of scientists at Tesla Motors (Nasdaq:...
Read More
Just a couple of weeks ago, in a single day, not just one but two U.S.-listed high-yielding companies moved to either significantly reduce or eliminate their dividends. Honestly, even one would have been big news. Both… Read More
